Yuhan outperforms Hanmi in sales

With disclosure of major pharmaceutical firms’ business performance last year in regulatory filings, Yuhan Corporation bulked up its market cap to 592.7 billion won last year, up 23.5 percent from the previous year, while Hanmi recorded 558.3 billion in sales.

Buoyed by robust earnings in the last quarter for flagship products, Yuhan set its sales target of 650 billion won this year.

By s...